341 studies found for:    Open Studies | "Macular Degeneration"
Show Display Options
Rank Status Study
21 Unknown  Prevention of Vision Loss in Patients With Age-Related Macular Degeneration (AMD) by Intravitreal Injection of Bevacizumab and Ranibizumab
Condition: Age-Related Neovascular Macular Degeneration
Interventions: Drug: bevacizumab;   Drug: ranibizumab
22 Recruiting Evaluation of Oral Minocycline in the Treatment of Geographic Atrophy Associated With Age-Related Macular Degeneration
Condition: Age- Related Macular Degeneration
Interventions: Drug: Minocycline;   Other: Placebo
23 Unknown  Copaxone in Age Related Macular Degeneration
Condition: Macular Degeneration
Intervention: Drug: Copaxone (Glatiramer acetate)
24 Recruiting Study of Dark Adaptation in Age-Related Macular Degeneration
Condition: Age-Related Macular Degeneration
25 Unknown  Photodynamic Therapy Combined With Bevacizumab vs Bevacizumab Alone for Neovascular Age-Related Macular Degeneration
Condition: Neovascular Age-Related Macular Degeneration
Intervention: Drug: Bevacizumab (Avastin), Verteporfin (Visudyne)
26 Recruiting Evaluation the Pharmacokinetics, Safety, Tolerability of TK001 in Patients With Neovascular Age-related Macular Degeneration
Condition: Neovascular Age-related Macular Degeneration
Intervention: Biological: TK001
27 Unknown  A Safety And Efficacy Study Of ALG-1001 In Human Subjects With Wet Age-Related Macular Degeneration
Condition: Macular Degeneration
Intervention: Drug: ALG 1001
28 Recruiting Photodynamic Therapy for PDA in NV AMD
Conditions: Neovascular Age-related Macular Degeneration;   Macular Degeneration
Intervention: Other: No Intervention
29 Unknown  Intravitreal Bevacizumab for Age-Related Macular Degeneration
Condition: Age Related Macular Degeneration
Intervention: Drug: bevacizumab intravitreal injection
30 Recruiting A Phase 2/3 Trial to Assess the Safety and Efficacy of Intravitreous Administration of Zimura® (Anti-C5 Aptamer) in Subjects With Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
Conditions: Geographic Atrophy;   Macular Degeneration
Interventions: Drug: Zimura®;   Drug: Sham
31 Recruiting Intravitreal Bone Marrow-Derived Stem Cells in Patients With Macular Degeneration
Condition: Age Related Macular Degeneration and Stargartd
Intervention: Other: intravitreal injection of autologous bone marrow stem cells
32 Not yet recruiting Five-year Incidence of Age-related Macular Degeneration in the Central Region of Portugal
Condition: Age-Related Macular Degeneration
33 Unknown  Manta Study: Avastin Versus Lucentis in Age Related Macular Degeneration
Condition: Age Related Macular Degeneration
Interventions: Drug: Ranibizumab;   Drug: Bevacizumab
34 Recruiting Subthreshold Laser Treatment for Reticular Pseudodrusen and Geographic Atrophy Secondary to Age-Related Macular Degeneration
Conditions: Age-Related Macular Degeneration;   Geographic Atrophy;   Reticular Pseudodrusen
Intervention: Procedure: Subthreshold 577 nm yellow wavelength laser photo-coagulator
35 Recruiting Intravitreal Aflibercept in Wet Age Related Macular Degeneration Patients With an Incomplete Response to Routine Ranibizumab Injections
Condition: Age Related Macular Degeneration
Intervention: Drug: Aflibercept
36 Recruiting Non-exudative Age-related Macular Degeneration
Condition: Non-exudative Age-related Macular Degeneration
37 Recruiting Time to Treatment Utilizing a Tele-Retinal Referral System for Wet Age Related Macular Degeneration and Diabetic Macular Edema: A Pilot Study
Conditions: Wet Age Related Macular Degeneration;   Diabetic Macular Edema
38 Recruiting A Prospective, Observational, Multicentre, 2 Year Study Evaluating the Use of Eylea (Aflibercept) for the Treatment of Neovascular (Wet) Age-related Macular Degeneration in UK NHS Opthalmology Clinics
Condition: Wet Age-related Macular Degeneration
39 Not yet recruiting Microperimetry and Eye Progressing From Stage 3 to Stage 4 Age-related Macular Degeneration (AMD)
Condition: Stage 3 Age Related Macular Degeneration (AREDS Classification)
Intervention: Device: MAIA™ (Centrevue, Padova, Italy; distributed in France by EDC Lamy, Carvin, France)
40 Recruiting Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Condition: Macular Degeneration
Interventions: Drug: abicipar pegol;   Drug: ranibizumab;   Other: sham procedure

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years